Teva Pharmaceuticals USA Inc 2022-09-07 Health serious FDA
Health · FDA · Recall #FDA-D-1473-2022
Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA… Recall
Issued September 7, 2022 · Teva Pharmaceuticals USA Inc
In September 2022, Teva Pharmaceuticals USA Inc recalled the Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.
What you should do
- 1 Stop using Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Teva Pharmaceuticals USA Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Teva Pharmaceuticals USA Inc
- Category
- Health
- Recall date
- September 7, 2022
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-1473-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Teva Pharmaceuticals USA Inc has 8 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.